Campath Alternatives Compared
Campath | Imbruvica | Ibrutinib |
|
---|
Campath (alemtuzumab) | Imbruvica (ibrutinib) | Ibrutinib |
|
|||||||
---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Chronic Lymphocytic Leukemia. Campath may also be used for purposes not listed in this medication guide. |
Prescription only
Imbruvica is an oral tablet that may be taken once daily to treat certain types of cancers in adults or to treat chronic Graft Versus Host disease in adults and children older than 1 year. It works... View more |
Prescription only
Prescribed for Chronic Lymphocytic Leukemia, Waldenström Macroglobulinemia, Graft-versus-host disease. ibrutinib may also be used for purposes not listed in this medication guide. |
Related suggestions Chronic Lymphocytic Leukemia
|
|||||||
More about Campath (alemtuzumab) | More about Imbruvica (ibrutinib) | More about Ibrutinib | ||||||||
Ratings & Reviews | ||||||||||
Be the first to share your experience with this drug. |
Imbruvica has an average rating of 6.3 out of 10 from a total of 59 ratings on Drugs.com. 56% of reviewers reported a positive effect, while 35% reported a negative effect. |
Ibrutinib has an average rating of 6.5 out of 10 from a total of 73 ratings on Drugs.com. 60% of reviewers reported a positive effect, while 31% reported a negative effect. |
||||||||
Drug Class | ||||||||||
Side Effects | ||||||||||
See also: Campath side effects in more detail. |
See also: Imbruvica side effects in more detail. |
See also: ibrutinib side effects in more detail. |
||||||||
Generic Availability | ||||||||||
N/A |
N/A |
|||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Imbruvica prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
Dosage Form(s) Available | ||||||||||
N/A |
|
N/A |
||||||||
Brand Names | ||||||||||
Other alemtuzumab brands include: Lemtrada |
N/A |
Imbruvica | ||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||
288 hours |
6 hours |
6 hours |
||||||||
CSA Schedule ** View glossary of terms | ||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category | ||||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
||||||||
Drug Interactions | ||||||||||
A total of 472 drugs are known to interact with Campath:
|
A total of 457 drugs are known to interact with Imbruvica:
|
A total of 457 drugs are known to interact with ibrutinib:
|
||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
|
||||||||
Disease Interactions | ||||||||||
First Approval Date | ||||||||||
N/A |
November 13, 2013 |
November 13, 2013 |
||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||
N/A |
N/A |
N/A |
||||||||
More Information | ||||||||||
Patient resources | ||||||||||
Professional Resources | ||||||||||
Related Treatment Guide | ||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.